StockData
BioCryst Pharmaceuticals Inc logo

BioCryst Pharmaceuticals Inc (BCRX) stock

BCRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30
$7.50+0.05 (+0.67%)

Close on Nov 17, 2026Market cap $1.92BP/E –Yield –

BioCryst Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

BioCryst Pharmaceuticals's total debt was $395.40M at Jun 30, 2026. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $314.87M in fiscal 2024.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0-100.0%
FY2024Dec 31, 2024$314.87M+3.8%
FY2023Dec 31, 2023$303.23M+30.9%
FY2022Dec 31, 2022$231.62M+70.2%
FY2021Dec 31, 2021$136.08M+13.7%
FY2020Dec 31, 2020$119.74M–
FY2019Dec 31, 2019$0-100.0%
FY2014Dec 31, 2014$30.00M0.0%
FY2013Dec 31, 2013$30.00M0.0%
FY2012Dec 31, 2012$30.00M0.0%
FY2011Dec 31, 2011$30.00M–
FY2010Dec 31, 2010$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$395.40M+62.9%
Q1 FY2026Mar 31, 2026$395.20M+25.3%
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$194.37M-38.2%
Q2 FY2025Jun 30, 2025$242.79M-22.6%
Q1 FY2025Mar 31, 2025$315.41M+2.2%
Q4 FY2024Dec 31, 2024$314.87M+3.8%
Q3 FY2024Sep 30, 2024$314.33M+5.5%
Q2 FY2024Jun 30, 2024$313.82M+7.0%
Q1 FY2024Mar 31, 2024$308.48M+32.7%
Q4 FY2023Dec 31, 2023$303.23M+30.9%
Q3 FY2023Sep 30, 2023$298.00M+33.1%
Q2 FY2023Jun 30, 2023$293.18M+102.9%
Q1 FY2023Mar 31, 2023$232.52M+65.8%
Q4 FY2022Dec 31, 2022$231.62M+70.2%
Q3 FY2022Sep 30, 2022$223.87M+69.5%
Q2 FY2022Jun 30, 2022$144.52M+14.0%
Q1 FY2022Mar 31, 2022$140.24M+14.0%
Q4 FY2021Dec 31, 2021$136.08M+13.7%
Q3 FY2021Sep 30, 2021$132.05M–
Q2 FY2021Jun 30, 2021$126.80M–
Q1 FY2021Mar 31, 2021$123.04M–
Q4 FY2020Dec 31, 2020$119.74M–
Q4 FY2019Dec 31, 2019$0–

More BioCryst Pharmaceuticals figures

See a number that looks wrong?